Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Willis Towers WatsonFRA:WTY +0.82%77 Days Sales Outstanding is 68.10 as of Jun. 2026, which is 4% above its 10-year median of 65.17. GuruFocus rates FRA:WTY with a GF Score™ of 77/100 and a GF Value™ of €286.64 (Fairly Valued). The stock has 3 warning signs investors should review. Among 59 Insurance companies, Willis Towers Watson ranks worse than 59.32% on this metric.
Willis Towers Watson (FRA:WTY) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Willis Towers Watson Days Sales Outstanding Related Terms
Willis Towers Watson Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Willis Towers Watson's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:WTY vs BRO, ERIE, NP: Days Sales Outstanding Comparison
For the Insurance Brokers subindustry, Willis Towers Watson's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Willis Towers Watson Days Sales Outstanding vs Insurance Industry
For the Insurance industry and Financial Services sector, Willis Towers Watson's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Willis Towers Watson's Days Sales Outstanding falls into.
Willis Towers Watson Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Willis Towers Watson (FRA:WTY) has a Days Sales Outstanding of 68.10 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Willis Towers Watson and its competitors. This is near median its historical median of 65.17. Over the past decade, Willis Towers Watson's Days Sales Outstanding has ranged from 58.54 to 89.78. According to the industry distribution chart, Willis Towers Watson ranks #35 out of 59 companies in the Insurance industry, placing it in the top 59.3%.
Is Willis Towers Watson's Days Sales Outstanding too high?
Willis Towers Watson's current Days Sales Outstanding of 68.10 is near median its 10-year median of 65.17. Over the past 10 years, this metric has ranged from a low of 58.54 to a high of 89.78. The Insurance industry median Days Sales Outstanding is 44.39. Willis Towers Watson's value of 68.10 is 53.4% above this industry median. Based on the distribution chart, Willis Towers Watson ranks #35 out of 59 companies in the Insurance industry, which is below the industry midpoint. Overall, Willis Towers Watson has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Willis Towers Watson's Days Sales Outstanding compare to BRO and ERIE?
According to the Insurance industry distribution chart, Willis Towers Watson ranks #35 out of 59 companies for Days Sales Outstanding. This places Willis Towers Watson in the lower half of its industry. The industry median Days Sales Outstanding is 44.39. Willis Towers Watson's value of 68.10 is 53.4% above this benchmark. Historically, Willis Towers Watson's own Days Sales Outstanding has ranged from 58.54 to 89.78 over the past decade. While the company's 10-year median is 65.17 vs. the industry median of 44.39, Willis Towers Watson has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for an Insurance company?
The median Days Sales Outstanding among Insurance companies is 44.39, based on 59 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Willis Towers Watson's current Days Sales Outstanding of 68.10 is 53.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Willis Towers Watson and its competitors. For the Insurance industry, the median Days Sales Outstanding is 44.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Willis Towers Watson's current Days Sales Outstanding is 68.10, which is near median its own 10-year median of 65.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Willis Towers Watson stock overvalued right now?
Based on GuruFocus' analysis, Willis Towers Watson (FRA:WTY) is currently considered Fairly Valued. The stock's GF Value™ is €286.64, compared to a current price of €270.60 — trading 5.6% below its estimated fair value. The current Days Sales Outstanding is 68.10, which is near median its 10-year median of 65.17 and 53.4% above the Insurance industry median of 44.39. Willis Towers Watson's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Willis Towers Watson (FRA:WTY), the current Days Sales Outstanding is 68.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Willis Towers Watson (FRA:WTY) Overvalued in 2026?
Based on GuruFocus' analysis, Willis Towers Watson stock appears to be undervalued.
The current stock price of €270.60 is trading 5.6% below its estimated GF Value™ of €286.64.
GuruFocus considers Willis Towers Watson to be Fairly Valued.
Key valuation signals for FRA:WTY:
Days Sales Outstanding: 68.10 (near median its 10-year median of 65.17)
GF Value™: €286.64 vs. price of €270.60 (5.6% below fair value)
Industry Position: 53.4% above the Insurance median (#35 of 59)
No single metric tells the full story. See the FRA:WTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.
77GF Score
Get the complete analysis for FRA:WTY
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:WTY has been successfully added to your 
